EUVIMEDEUVIMED entdecken
Crossref

Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis

Qiaofang Liao, Jing Hu, Zhengyu Wu, Yanhui Jiang, Di Cheng, Huimou Chen iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Qiaofang Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Huizhou Affiliated Hospital of Guangdong Medical University, Huizhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Rhabdomyosarcoma, Proto-Oncogene Proteins c-akt, Phenanthrenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhabdomyosarcoma (RMS) is an aggressive pediatric soft tissue sarcoma with limited treatment options and poor prognosis. Dihydrotanshinone I (DT), a bioactive compound from Danshen, exhibits anti‐inflammatory and antitumor properties, but its effects on RMS remain unclear. To investigate the mode of cell death induced by DT, various inhibitors were employed. RNA sequencing and co‐immunoprecipitation assays were utilized to explore the mechanism of DT‐induced ferroptosis in RMS. Furthermore, the anti‐RMS efficacy of DT was evaluated through in vitro experimental models and nude mouse xenograft models. We found that DT induces the ubiquitination and degradation of HSP90AA1, thereby inhibiting the HSP90AA1/RACK1/AKT signaling axis and subsequently triggering ferroptosis in RMS. This process significantly suppresses the proliferation of RMS. These findings highlight the potential of DT as a therapeutic candidate for RMS and propose a ferroptosis‐targeting strategy that may improve treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisRhabdomyosarcomaProto-Oncogene Proteins c-aktPhenanthrenesHSP90 Heat-Shock ProteinsNeoplasm ProteinsAnimalsHumansCell Line, TumorMice, NudeMiceSignal TransductionXenograft Model Antitumor AssaysCell ProliferationFuransQuinones

Stichwörter der Autor:innen

Dihydrotanshinone IHSP90AA1RACK1ferroptosisrhabdomyosarcoma

Substanzen

dihydrotanshinone IProto-Oncogene Proteins c-aktPhenanthrenesHSP90 Heat-Shock ProteinsNeoplasm ProteinsFuransQuinones

Autor:innen und Institutionen

  • Department of Oncology, The First Huizhou Affiliated Hospital of Guangdong Medical University, Huizhou, China.
  • Department of Oncology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Biomedical Innovation Center, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Department of Radiotherapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Huimou Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liao, Q., Hu, J., Wu, Z., Jiang, Y., Cheng, D., & Chen, H. (2026). Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70295

Vancouver

Liao Q, Hu J, Wu Z, Jiang Y, Cheng D, Chen H. Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70295

BibTeX
@article{Liao2026,
  author = {Liao, Qiaofang and Hu, Jing and Wu, Zhengyu and Jiang, Yanhui and Cheng, Di and Chen, Huimou},
  title = {Dihydrotanshinone I Induces Ferroptosis in Rhabdomyosarcoma by Targeting HSP90AA1 / RACK1 / AKT Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70295}
}
Kostenlos starten →